Effect of ischemic preconditioning on myocardial oxygen consumption during ischemia

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 11, 1998, Pages 2165-2174

  Xu, Zhe Long ^a   Endoh, Hiroshi ^a   Ishihata, Akira ^a   Takahashi, Eiji ^a   Doi, Katsuhiko ^a  

^a YAMAGATA UNIVERSITY   (Japan)

Author keywords

Cytochrome aa3 redox state; Ischemic preconditioning; Mitochondrial respiratory chain; Nitric oxide; Oxygen consumption; Spectrophotometry

Indexed keywords

CYTOCHROME C OXIDASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION PREVENTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE OXYGEN CONSUMPTION; MALE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; RAT; RESPIRATORY CHAIN; SPECTROPHOTOMETRY; TIME;

ANIMALIA;

EID: 0032212884     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0771     Document Type: Article

References (45)

1. ALBUQUERQUE CP, GERSTENBLITH G, WEISS RG, 1994. Importance of metabolic inhibition and cellular pH in mediating preconditioning contractile and metabolic effects in rat hearts. Circ Res 74: 139-150.
2. ASIMAKIS GK, INNERS-MCBRIDE K, MEDELLIN G, CONTI VR, 1992. Ischemic preconditioning attenuates acidosis and postischemic dysfunction in isolated rat heart. Am J Physiol 263: H887-H894.
3. BALABAN RS, 1990. Regulation of oxidative phosphorylation in the mammalian cell. Am J Physiol 258: C377-C389.
4. BASHFORD CL, BARLOW CH, CHANCE B, HASELGROVE J, 1980. The oxidation-reduction state of cytochrome oxidase in freeze trapped gerbil brains. FEBS Lett 113: 78-80.
5. BOLLI R, 1990. Mechanism of myocardial "stunning". Circulation 82: 723-738.
6. BOLLI R, BHATTI ZA, TANG XL, QIU Y, ZHANG Q, GUO Y, JADOON AK, 1997. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 81: 42-52.
7. BRAUNWALD E, KLONER RA, 1982. The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation 66: 1146-1149.
8. BROWN GC, 1995. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 369: 136-139.
9. CARGNONI A, CECONI C, BERNOCCHI P, PASINI E, CURELLO S, FERRARI R, 1996. Is stunning an important component of preconditioning? J Mol Cell Cardiol 28: 2323-2331.
10. CAVE AC, APSTEIN CS, 1996. Polymyxin B, a protein kinase c inhibitor, abolishes preconditioning-induced protection against contractile dysfunction in the isolated blood perfused rat heart. J Mol Cell Cardiol 28: 977-987.
11. CLEETER MWJ, COOPER JM, DARLEY-USMAR VM, MONCADA S, SCHAPIRA AHV, 1994. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide. FEBS Lett 345: 50-54.
12. FROM AHL, ZIMMER SD, MICHURSKI SP, MOHANAKRISHNAN P, ULSTAD VK, THOMA WJ, UGURBIL K, 1990. Regulation of the oxidative phosphorylation rate in the intact cell. Biochemistry 29: 3731-3743.
13. GARNIER A, ROSSI A, LAVANCHY N, 1996. Importance of the early alterations of energy metabolism in the induction and the disappearance of ischemic preconditioning in the isolated rat heart. J Mol Cell Cardiol 28: 1671-1682.
14. GRANGER DL, LEHNINGER AL, 1982. Sites of inhibition of mitochondrial electron transport in macrophage-injured neoplastic cells. J Cell Biol 95: 527-535.
15. 0 ATPase inhibition. Am J Physiol 274: H90-H97.
16. GRUND F, SOMMERSCHILD HT, KIRKEBOEN KA, ILEBEKK A, 1997. Preconditioning with ischaemia reduces both myocardial oxygen consumption and infarct size in a graded pattern. J Mol Cell Cardiol 29: 3067-3079.
17. HARTMAN JC, HOUSHYAR H, LEVA SC, WALL TM, 1995. A role for nitric oxide in myocardial ischemic preconditioning (Abstract). Circulation 92: I-716.
18. HASSINEN IE, 1986. Mitochondrial respiratory control in the myocardium. Biochim Biophys Acta 853: 135-151.
19. HASSINEN IE, HILTUNEN K, 1975. Respiratory control in isolated perfused rat heart. Role of the equilibrium relations between the mitochondrial electron carriers and the adenylate system. Biochim Biophys Acta 408: 319-330.
20. HASSINEN IE, HILTUNEN JK, TAKALA TES, 1981. Reflectance spectrophotometric monitoring of the isolated perfused heart as a method of measuring the oxidation-reduction state of cytochromes and oxygenation of myoglobin. Cardiovasc Res 15: 86-91.
21. HEINEMAN FW, KUPRIYANOV VV, MARSHALL R, FRALIX TA, BALABAN RS, 1992. Myocardial oxygenation in the isolated working rabbit heart as a function of work. Am J Physiol 262: H255-H267.
22. 3 by oxygen plus carbon dioxide at hyperbaric pressures. J Appl Physiol 43: 873-879.
23. JANATI-IDRISSI R, BESSON B, LAPLACE M, BUI MH, 1995. In situ mitochondrial function in volume overload- and pressure overload-induced cardiac hypertrophy in rats. Basic Res Cardiol 90: 305-313.
24. 1H nuclear magnetic resonance studies of sarcoplasmic oxygenation in the red cell-perfused rat heart. Biophys J 68: 2129-2136.
25. JENNINGS RB, MURRY CE, REIMER KA, 1991. Energy metabolism in preconditioned and control myocardium: effect of total ischemia. J Mol Cell Cardiol 23: 1449-1458.
26. 3 in vivo. J Appl Physiol 43: 858-872.
27. KOLOCASSIDES KG, GALINANES M, HEARSE DJ, 1995. Preconditioning accelerates contracture and ATP depletion in blood-perfused rat hearts. Am J Physiol 269: H1415-H1420.
28. LASTER SB, BECKER LC, AMBROSIO G, JACOBUS WE, 1989. Reduced aerobic metabolic efficiency in globally "stunned" myocardium. J Mol Cell Cardiol 21: 419-426.
29. LU HR, REMEYSEN P, DE CLERCK F, 1995. Does the antiarrhythmic effect of ischemic preconditioning in rats involve the L-arginine nitric oxide pathway? J Cardiovasc Pharmacol 25: 524-530.
30. MATSUDA M, CATENA TG, HEIDE RSV, JENNINGS RB, REIMER KA, 1993. Cardiac protection by ischaemic preconditioning is not mediated by myocardial stunning. Cardiovasc Res 27: 585-592.
31. MIURA T, GOTO M, URABE K, ENDOH A, SHIMAMOTO K, IIMURA O, 1991. Does myocardial stunning contribute to infarct size limitation by ischemic preconditioning? Circulation 84: 2504-2512.
32. MURRY CE, JENNINGS RB, REIMER KA, 1986. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136.
33. MURRY CE, RICHARD VJ, REIMER KA, JENNINGS RB, 1990. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66: 913-931.
34. MURRY CE, RICHARD VJ, JENNINGS RB, REIMER KA, 1991. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol 260: H796-H804.
35. ROUSLIN W, 1983. Protonic inhibition of the mitochondrial oligomycin-sensitive adenosine 5′-tri-phosphatase in ischemic and autolyzing cardiac muscle. J Biol Chem 258: 9657-9661.
36. 3 in the in-situ canine heart. J Appl Cardiol 3: 191-196.
37. 3 in the in situ canine heart to transient ischemic episodes. Basic Res Cardiol 76: 289-304.
38. TAMURA M, OSHINO N, CHANCE B, SILVER IA, 1978. Optical measurements of intracellular oxygen concentration of rat heart in vitro. Arch Biochem Biophys 191: 8-22.
39. VEGH A, SZEKERES L, PARRATT J, 1992. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway. Br J Pharmacol 107: 648-652.
40. o-ATPaSe. Circulation 91: 2810-2818.
41. WESELCOUCH EO, BAIRD AJ, SLEPH P, GROVER GJ, 1995. Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts. Am J Physiol 268: H242-H249.
42. WILSON DF, 1994. Factors affecting the rate and energetics of mitochondrial oxidative phosphorylation. Med Sci Sports Exerc 26: 37-43.
43. WOLFE CL, SIEVERS RE, VISSEREN FLJ, DONNELLY TJ, 1993. Loss of myocardial protection after preconditioning correlates with the time course of glycogen recovery within the preconditioned segment. Circulation 87: 881-892.
44. XIE YW, SHEN W, ZHAO G, XU X, WOLIN MS, HINTZE TH, 1996. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Circ Res 79: 381-387.
45. YELLON DM, BAXTER GF, GARCIA-DORADO D, HEUSCH G, SUMERAY MS, 1998. Ischaemic preconditioning: present position and future directions. Cardiovasc Res 37: 21-33.